Table 1 Characteristics of study populations
| Â | T2DM patients | Healthy volunteers | P |
|---|---|---|---|
Mean ± SD/median [IQR] | Mean ± SD/median [IQR] | ||
Gender (M:F) | 82:43 | 61:40 | 0.45 |
Age (years) | 58 ± 7 | 57 ± 8 | 0.24 |
Height (cm) | 170 ± 9 | 171 ± 9 | 0.36 |
BMI (kg/m2) | 28.6 ± 4.2 | 26.1 ± 3.6 | <0.0001 |
Obesity (%) | 26.4 | 9.0 | 0.0001 |
Waist circumference (cm) | 104 ± 11 | 93 ± 10 | <0.0001 |
Heart rate (bpm) | 68 ± 11 | 62 ± 10 | <0.0001 |
Systolic/diastolic BP (mmHg) | 138 ± 17/80±9 | 121 ± 11/75±7 | <0.0001 |
LDL-cholesterol (mmol/L) | 2.89 ± 0.72 | 3.11 ± 0.93 | 0.10 |
HDL-cholesterol (mmol/L) | 1.28 ± 0.31 | 1.48 ± 0.34 | <0.0005 |
Triglycerides (mmol/L) | 1.33 [0.94] | 1.11 [0.73] | 0.001 |
Fasting glucose (mmol/L) | 7.0 ± 1.8 | 5.1 ± 0.5 | <0.0001 |
HbAc1 (%) | 7.0 [1.3] | Â | Â |
T2DM duration (years) | 7.1 ± 6.4 |  |  |
Current smoking (%) | 35.2 | 29.1 | 0.26 |
BP-lowering treatment (%) | 52.8 | 0 | <0.0001 |
Lipid-lowering treatment (%) | 44.0 | 0 | <0.0001 |